Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
23.1M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
896K
-
Shares change
-
0
-
Total reported value, excl. options
-
$2.28M
-
Price
-
$2.55
Significant Holders of Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) as of Q4 2023
1 filings reported holding TSBX - Turnstone Biologics Corp. - Common Stock, par value $0.001 per share as of Q4 2023.
Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 896K shares
of 23.1M outstanding shares and own 3.87% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.1M shares), FMR LLC (2.55M shares), BANK OF AMERICA CORP /DE/ (914K shares), TAKEDA PHARMACEUTICAL CO LTD (896K shares), Point72 Asset Management, L.P. (833K shares), EVENTIDE ASSET MANAGEMENT, LLC (708K shares), CITADEL ADVISORS LLC (688K shares), PFM Health Sciences, LP (633K shares), 72 Investment Holdings, LLC (550K shares), and SECTORAL ASSET MANAGEMENT INC (518K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.